Table 3.
Advantages | Disadvantages | Implementation considerations |
---|---|---|
• Preventive approach to unethical behavior (7, 23) • Protection of physicians' professional judgment and patient care (2) • Easier justification of this action in line with the public interest (7) • Attracting public trust in the health system • Management of pharmaceutical costs • The threat caused by regulations can be the motivation to change professional behavior (48) |
• Loss of industry financial support for educational and research programs, especially continuing education programs (29) • Political impossibility (unpopular among affected groups such as physicians) (7) • The information gap is caused by the lack of communication between physicians and pharmaceutical representatives (38) • The need for strict supervision and clear legal sanctions (41) • Limited effect (40) • Payment by unobservable methods (such as cryptocurrency) |
• Requires an official law approved by the parliament • Lobbying and negotiating with various influential institutions and groups for the approval of the law • Compilation of executive and penal regulations for non-compliance with the prohibition law (7, 48) • Close monitoring of law enforcement and support for whistleblowers to report violations (52) • Launching an up-to-date pharmaceutical information system to compensate for the lack of relationship between physicians and pharmaceutical representatives |